Page last updated: 2024-09-04

ertapenem and Critical Illness

ertapenem has been researched along with Critical Illness in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanco, VM; Camargo, RD; Correa, A; Cuesta, DP; Florez, E; Hernández-Gómez, C; Matta, L; Maya, JJ; Motoa, G; Muñoz, M; Nagles, J; Ovalle, A; Reyes, S; Rosso, F; Vallejo, ME; Villegas, MV	1
DePestel, DD; Eyler, RF; Heung, M; Kinzig, M; Mueller, BA; Nader, AM; Pleva, M; Sörgel, F; Sowinski, KM; Vilay, AM	1
Burkhardt, O; Fliser, D; Hafer, C; Haller, H; Kaever, V; Kielstein, JT; Kumar, V; Langhoff, A; Welte, T	1
Brink, AJ; Kiem, S; Richards, GA; Schentag, J; Schillack, V	1
Burkhardt, O; Derendorf, H; Kielstein, JT; Kumar, V; Schmidt, S; Welte, T	1
Boselli, E; Breilh, D; Fleureau, C; Gordien, JB; Janvier, G; Joanes-Boyau, O; Rapaport, S; Saux, MC; Texier-Maugein, J	1
Burkhardt, O; Derendorf, H; Drewelow, B; Katterwe, D; Kumar, V; Majcher-Peszynska, J; Welte, T	1
Burkhardt, O; Derendorf, H; Welte, T	1

Reviews

1 review(s) available for ertapenem and Critical Illness

Article	Year
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections	2007

Article

Year

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.

Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2

Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections

2007

Trials

1 trial(s) available for ertapenem and Critical Illness

Article	Year
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Female; Gram-Negative Bacterial Infections; Hemofiltration; Humans; Male; Middle Aged; Renal Dialysis	2014

Other Studies

6 other study(ies) available for ertapenem and Critical Illness

Article	Year
[Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2019, Volume: 36, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Colombia; Critical Illness; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pseudomonas; Risk Factors; Statistics, Nonparametric; Time Factors; Treatment Outcome	2019
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:1 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Administration Schedule; Ertapenem; Female; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Renal Dialysis	2009
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. International journal of antimicrobial agents, 2009, Volume: 33, Issue:5 Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Chromatography, High Pressure Liquid; Cohort Studies; Critical Illness; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Prospective Studies; Sepsis; Time Factors; Urine; Young Adult	2009
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. International journal of antimicrobial agents, 2010, Volume: 35, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Humans; Monte Carlo Method; Plasma; Pneumonia, Bacterial	2010
Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion. Minerva anestesiologica, 2011, Volume: 77, Issue:11 Topics: Aged; Anti-Bacterial Agents; Bacteria; beta-Lactams; Critical Illness; Ertapenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis	2011
Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Creatinine; Critical Illness; Ertapenem; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Treatment Outcome	2007